A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

Clinical trial NCT02500667 · COMPLETED

Trial details

NCT number: NCT02500667
Sponsor: Nivalis Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interaction Potentiation

Start date: 2015-06-01
Primary completion: 2015-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.